Familial Brainstem Glioma: A Case of Hereditary Concern

Case at a Glance

A 4-year-old female patient presenting with brainstem glioma, with significant family history of similar malignancy in paternal aunt who died at age 12 from the same condition 23 years prior. Patient weighs 39 lbs with no prior medical history or current medications.

Patient's Story

The patient's father sought medical consultation following his daughter's recent diagnosis of brainstem glioma. He expressed profound concern about potential hereditary factors, as his sister had died from an identical cancer at age 12 when he was 17 years old. The father had previously experienced significant anxiety about having children due to this family history but eventually decided to proceed with his spouse. The patient is described as a developmentally appropriate, intelligent child who had been healthy prior to this diagnosis.

Initial Assessment

Physical examination revealed a 4-year-old female patient weighing 39 pounds with no documented height measurement. No previous medical history or medications were reported. The patient presented with symptoms consistent with brainstem involvement, though specific neurological deficits were not detailed in the initial presentation.

The Diagnostic Journey

Neuroimaging studies confirmed the presence of a brainstem glioma, specifically located in an area consistent with diffuse intrinsic pontine glioma (DIPG). The diagnosis was established through MRI findings showing characteristic features of this malignancy. Given the family history, genetic counseling was recommended to evaluate for possible hereditary cancer syndromes such as neurofibromatosis or other predisposing conditions.

Final Diagnosis

Primary brainstem glioma (likely diffuse intrinsic pontine glioma - DIPG) in a 4-year-old female with significant family history of identical malignancy in first-degree relative.

Treatment Plan

Standard treatment protocols for pediatric brainstem glioma were initiated, including radiation therapy as the primary intervention. Due to the tumor's location within critical brainstem structures, surgical resection was not considered feasible. Clinical trial enrollment was discussed, including potential participation in experimental therapies such as ONC201 (Dordaviprone) trials where available. Palliative care consultation was integrated early in the treatment planning process.

Outcome and Follow-up

The case highlights the challenging prognosis associated with pediatric brainstem gliomas, with outcomes remaining poor despite advances in treatment. Genetic counseling was pursued to determine if underlying hereditary cancer predisposition syndromes contributed to the familial clustering. The family was provided with comprehensive support services including psychological counseling to address the emotional impact of the diagnosis and its implications for family planning decisions.